{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "CARDIOVASCULAR SYSTEM" , "@language" : "en" } ,        { "@value" : "Kardiovaskul\u00E1rn\u00ED syst\u00E9m" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C10",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Lipid modifying agents" , "@language" : "en" } ,        { "@value" : "L\u00E9\u010Diva ovliv\u0148uj\u00EDc\u00ED hladinu lipid\u016F" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C10" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C10A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "L\u00E9\u010Diva ovliv\u0148uj\u00EDc\u00ED hladinu lipid\u016F, samotn\u00E1" , "@language" : "cs" } ,        { "@value" : "Lipid modifying agents, plain" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C10A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C10AA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Inhibitory HMG CoA redukt\u00E1zy" , "@language" : "cs" } ,        { "@value" : "HMG CoA reductase inhibitors" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C10AA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C10AA05",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/C10A" ,        "http://linked.opendata.cz/resource/ATC/C10AA" ,        "http://linked.opendata.cz/resource/ATC/C" ,        "http://linked.opendata.cz/resource/ATC/C10" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Atorvastatin" , "@language" : "en" } ,        { "@value" : "Atorvastatin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C10AA05" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0324841",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Atorvastatin calcium" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/ATORVASTATIN--PHARMA-10-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0324841" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157815" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157816" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157817" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157818" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157811" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157812" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157813" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157814" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157807" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157808" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157809" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157810" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157806" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157823" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157824" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157825" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157819" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157820" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157821" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157822" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157806",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "4" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 4X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157807",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "7" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 7X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157808",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 10X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157809",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "14" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 14X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157810",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 20X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157811",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "28" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 28X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157812",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2010-07-01" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 119.4100036621094 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 119.4100036621094 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 30X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157813",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 50X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157814",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "56" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 56X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157815",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "84" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 84X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157816",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "98" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 98X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157817",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 100X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157818",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10X20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 200X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157819",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC154015_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "500" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Hypercholesterolemie\nAtorvastatin +pharma je indikov\u00E1n jako dopln\u011Bk k diet\u011B ke sn\u00ED\u017Een\u00ED zv\u00FD\u0161en\u00E9ho celkov\u00E9ho cholesterolu (TC), LDL-cholesterolu (LDL-C), apolipoproteinu B a triglycerid\u016F u dosp\u011Bl\u00FDch, dosp\u00EDvaj\u00EDc\u00EDch a d\u011Bt\u00ED ve v\u011Bku 10 let a star\u0161\u00EDch s\u00A0prim\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED, v\u010Detn\u011B famili\u00E1rn\u00ED hypercholesterol\u00E9mie (heterozygotn\u00ED forma) nebo s kombinovanou (sm\u00ED\u0161enou) hyperlipid\u00E9mi\u00ED (odpov\u00EDdaj\u00EDc\u00ED typu IIa nebo typu IIb podle Fredricksona), pokud dieta a jin\u00E1 nefarmakologick\u00E1 opat\u0159en\u00ED nebyla dostate\u010Dn\u011B \u00FA\u010Dinn\u00E1.\nAtorvastatin je t\u00E9\u017E indikov\u00E1n ke sn\u00ED\u017Een\u00ED celkov\u00E9ho cholesterolu a LDL-cholesterolu u dosp\u011Bl\u00FDch s homozygotn\u00ED famili\u00E1rn\u00ED hypercholesterol\u00E9mi\u00ED jako p\u0159\u00EDdatn\u00E1 l\u00E9\u010Dba k dal\u0161\u00ED hypolipidemick\u00E9 terapii (nap\u0159. LDL afer\u00E9za) nebo v p\u0159\u00EDpadech, kdy\u017E tyto l\u00E9\u010Debn\u00E9 metody nejsou dostupn\u00E9.\nPrevence kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED\nPrevence kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u dosp\u011Bl\u00FDch pacient\u016F s\u00A0p\u0159edpokl\u00E1dan\u00FDm vysok\u00FDm rizikem prvn\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody (viz bod 5.1), jako dopln\u011Bk p\u0159i \u00FAprav\u00E1ch dal\u0161\u00EDch rizikov\u00FDch faktor\u016F.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 500X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157820",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 10X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157821",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 20X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157822",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 30X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157823",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 50X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157824",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 100X10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157825",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ATORVASTATIN +PHARMA 10 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C10AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOLIPIDAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "200" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 200X10MG" , "@language" : "cs" } ] }] }